Nanodialysis at home dialysis congress Cologne

Nanodialysis presented the CORDIAL device at the home dialysis congress was held in Cologne (Germany), which was held o the 26th and 27th of April, 2024.

Start of First-in-Human study in Utrecht

This week we will start with the First-in-Human study in Utrecht.

Ethics committee approves start of First-in-Human investigation

Last week, the ethics committee approved the start of the First-in-Human investigation at the UMC Utrecht.

CORDIAL on ERA Congress Milan

Last week, Karin Gerritsen presented the WEAKID device and CORDIAL project on the ERA (European Renal Association) Congress in Milan, Italy.

WEAKID device: innovation in dialysis

Karin Gerritsen presented the WEAKID device as an innovation to improve the quality of life of kidney patients.

Ready for first-in-human study in 2023

We are ready for the ‘first-in-human’ study in 2023! After extensive developing and testing, the WEAKID peritoneal dialysis system is ready to be tested by actual dialysis patients.

Usability test in Madrid, Spain

On the 8th and 9th of November, usability tests were performed at SERMAS in Madrid, Spain, with 2 nurses and 2 patients.

3rd Consortium Meeting, 20 Oct 2022

On the 20th of October, 2022, we celebrated the achievements so far and discussed the details for the clinical study and looked further into the future.

Usability test in Modena, Italy

On the 7th and 8th of September usability tests were performed at UNIMORE in Modena, Italy, with 2 nurses and 2 patients.

Review published on continuous flow PD

In June 2022, partners from the CORDIAL consortium published a review that shows the potential of the technology but also the need for clinical evidence.